Why the study?
Previous studies evaluated the separate associations of arterial stiffness and blood pressure with PAD, but the risk stratification capacity of arterial stiffness beyond blood pressure status was unclear.
Does the combined evaluation of arterial stiffness and blood pressure improve risk stratification for incident peripheral arterial disease?
Does the combined evaluation of arterial stiffness and blood pressure improve risk stratification for incident peripheral arterial disease?
Combined assessment of arterial stiffness and blood pressure significantly improves risk prediction for incident peripheral arterial disease compared to blood pressure evaluation alone.
Answers are grounded in this paper and cite their sources.
Combined arterial stiffness and BP assessment may aid PAD risk stratification in cohorts; leaves open prospective validation before clinical use.
Background: Previous studies have reported the separate association of arterial stiffness (AS) and blood pressure with peripheral arterial disease (PAD). Objectives: The aim of this study was to investigate the risk stratification capacity of AS on incident PAD beyond blood pressure status. Methods: A total of 8,960 participants from Beijing Health Management Cohort were enrolled at the first health visit between 2008 and 2018 and then followed until the incidence of PAD or 2019. Elevated AS was defined as brachial-ankle pulse-wave velocity (baPWV) >1,400 cm/s, including moderate stiffness (1,400 ≤ baPWV <1,800 cm/s) and severe stiffness (baPWV ≥1,800 cm/s). PAD was defined as ankle-brachial index <0.9. A frailty Cox model was used to calculate the HR, integrated discrimination improvement, and net reclassification improvement. Results: During follow-up, 225 participants (2.5%) developed PAD. After adjusting for confounding factors, the highest risk for PAD was observed in the group with elevated AS and blood pressure (HR: 2.253; 95% CI: 1.472-3.448). Among participants with ideal blood pressure and those with well-controlled hypertension, PAD risk was still significant for severe AS. The results remained consistent in multiple sensitivity analyses. In addition, baPWV significantly improved the predictive capacity for PAD risk beyond systolic and diastolic blood pressures (integrated discrimination improvement 0.020 and 0.190, net reclassification improvement 0.037 and 0.303). Conclusions: This study suggests the clinical importance of combined evaluation and control of AS and blood pressure for the risk stratification and prevention of PAD.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: